A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemia

Lena Golick, Reeder M. Robinson, Leticia Reyes, Nadia St. Thomas, Kathleen Klinzing, Erin C. O’Connor, Leonardo M. R. Ferreira, Nathan G. Dolloff

Open source

DOI: 10.1038/s41408-025-01391-w
Published: 2025-11-17
Container: Blood Cancer Journal
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-025-01391-w,
  title = {A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemia},
  author = {Lena Golick and Reeder M. Robinson and Leticia Reyes and Nadia St. Thomas and Kathleen Klinzing and Erin C. O’Connor and Leonardo M. R. Ferreira and Nathan G. Dolloff},
  year = {2025},
  journal = {Blood Cancer Journal},
  doi = {10.1038/s41408-025-01391-w},
  url = {https://doi.org/10.1038/s41408-025-01391-w}
}

RIS

TY  - JOUR
TI  - A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemia
AU  - Lena Golick
AU  - Reeder M. Robinson
AU  - Leticia Reyes
AU  - Nadia St. Thomas
AU  - Kathleen Klinzing
AU  - Erin C. O’Connor
AU  - Leonardo M. R. Ferreira
AU  - Nathan G. Dolloff
PY  - 2025
JO  - Blood Cancer Journal
DO  - 10.1038/s41408-025-01391-w
UR  - https://doi.org/10.1038/s41408-025-01391-w
ER  -

APA

Golick, L., Robinson, R. M., Reyes, L., Thomas, N. S., Klinzing, K., O’Connor, E. C., Ferreira, L. M. R., & Dolloff, N. G. (2025). A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemia. Blood Cancer Journal. https://doi.org/10.1038/s41408-025-01391-w

Source records

crossref · retrieved 2026-09-26T06:49:57.320Z